Sg Americas Securities, LLC Bio Techne Corp Transaction History

Sg Americas Securities, LLC

$24.4 Billion
Q4 2024

A detailed history of Sg Americas Securities, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Sg Americas Securities, LLC holds 7,001 shares of TECH stock, worth $432,311. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,001

Previous 6,545 6.97%

Holding current value

$432,311

Previous $523,000 3.63%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	BUY	$66.37 - $78.17 $30,264 - $35,645	456 Added 6.97%	7,001 $504,000
Q3 2024 Oct 03, 2024	SELL	$70.96 - $82.35 $3.11 Million - $3.6 Million	-43,772 Reduced 86.99%	6,545 $523,000
Q2 2024 Jul 12, 2024	BUY	$62.12 - $84.15 $1.54 Million - $2.09 Million	24,794 Added 97.14%	50,317 $3.61 Million
Q1 2024 May 06, 2024	BUY	$65.98 - $77.09 $384,531 - $449,280	5,828 Added 29.59%	25,523 $1.8 Million
Q4 2023 Jan 12, 2024	BUY	$52.83 - $78.22 $730,797 - $1.08 Million	13,833 Added 235.98%	19,695 $1.52 Million
Q3 2023 Oct 13, 2023	SELL	$67.52 - $89.42 $348,335 - $461,317	-5,159 Reduced 46.81%	5,862 $399,000
Q2 2023 Jul 10, 2023	SELL	$73.76 - $85.98 $255,283 - $297,576	-3,461 Reduced 23.9%	11,021 $900,000
Q1 2023 Apr 28, 2023	SELL	$71.62 - $86.62 $504,992 - $610,757	-7,051 Reduced 32.75%	14,482 $1.07 Million
Q4 2022 Feb 02, 2023	BUY	$80.67 - $352.29 $1.34 Million - $5.86 Million	16,647 Added 340.71%	21,533 $1.79 Million
Q3 2022 Oct 31, 2022	BUY	$282.54 - $391.85 $355,435 - $492,947	1,258 Added 34.67%	4,886 $1.39 Million
Q2 2022 Jul 29, 2022	BUY	$322.67 - $449.65 $917,350 - $1.28 Million	2,843 Added 362.17%	3,628 $1.26 Million
Q1 2022 Apr 29, 2022	SELL	$353.85 - $487.79 $90,939 - $125,362	-257 Reduced 24.66%	785 $340,000
Q4 2021 Feb 07, 2022	SELL	$456.15 - $525.06 $4.04 Million - $4.65 Million	-8,847 Reduced 89.46%	1,042 $539,000
Q3 2021 Nov 01, 2021	BUY	$444.87 - $538.88 $521,387 - $631,567	1,172 Added 13.44%	9,889 $4.79 Million
Q2 2021 Aug 12, 2021	SELL	$387.35 - $450.26 $421,436 - $489,882	-1,088 Reduced 11.1%	8,717 $3.93 Million
Q1 2021 May 13, 2021	SELL	$314.62 - $411.0 $433,860 - $566,769	-1,379 Reduced 12.33%	9,805 $3.75 Million
Q4 2020 Feb 04, 2021	BUY	$246.9 - $321.87 $1.56 Million - $2.04 Million	6,326 Added 130.22%	11,184 $3.55 Million
Q3 2020 Nov 09, 2020	SELL	$232.22 - $282.96 $1.67 Million - $2.04 Million	-7,195 Reduced 59.69%	4,858 $1.2 Million
Q2 2020 Jul 20, 2020	BUY	$185.43 - $279.56 $1.91 Million - $2.87 Million	10,281 Added 580.19%	12,053 $3.18 Million
Q1 2020 Apr 30, 2020	BUY	$161.17 - $221.51 $65,918 - $90,597	409 Added 30.01%	1,772 $336,000
Q4 2019 Jan 28, 2020	SELL	$189.68 - $222.09 $72,457 - $84,838	-382 Reduced 21.89%	1,363 $299,000
Q3 2019 Nov 04, 2019	SELL	$183.56 - $216.72 $828,406 - $978,057	-4,513 Reduced 72.12%	1,745 $341,000
Q2 2019 Jul 29, 2019	BUY	$188.72 - $215.43 $648,819 - $740,648	3,438 Added 121.91%	6,258 $1.31 Million
Q1 2019 Apr 29, 2019	SELL	$136.09 - $200.44 $50,761 - $74,764	-373 Reduced 11.68%	2,820 $560,000
Q4 2018 Feb 01, 2019	SELL	$132.75 - $203.8 $565,382 - $867,984	-4,259 Reduced 57.15%	3,193 $462,000
Q3 2018 Nov 06, 2018	BUY	$147.44 - $204.11 $213,935 - $296,163	1,451 Added 24.18%	7,452 $1.52 Million
Q2 2018 Aug 07, 2018	SELL	$144.9 - $165.58 $302,696 - $345,896	-2,089 Reduced 25.82%	6,001 $888,000
Q1 2018 May 03, 2018	SELL	$131.46 - $151.04 $737,884 - $847,787	-5,613 Reduced 40.96%	8,090 $1.22 Million
Q4 2017 Jan 24, 2018	BUY	$121.17 - $134.75 $1.66 Million - $1.85 Million	13,703	13,703 $1.78 Million

Others Institutions Holding TECH

# of Institutions

619

Shares Held

156M

Call Options Held

161K

Put Options Held

12.7K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.42B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Bio Techne Corp Transaction History